Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells

British Journal of Cancer

Volumn 104, Issue 1, 2011, Pages 146-154

  Watanabe, T ^a   Semba, S ^a   Yokozaki, H ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BRG1; BRM; colorectal carcinoma; cyclin D1; PI3K Akt signalling pathway; PTEN

Indexed keywords

BRG1 PROTEIN; BRM PROTEIN; COMPLEMENTARY DNA; CYCLIN D1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC REGULATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; COLON; COLORECTAL NEOPLASMS; CYCLIN D1; DNA HELICASES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650898211     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6606018     Document Type: Article

References (50)

1. Barker N, Hurlstone A, Musisi H, Miles A, Bienz M, Clevers H (2001) The chromatin remodelling factor Brg-1 interacts with b-catenin to promote target gene activation. EMBO J 20: 4935-4943
2. Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R (2000) BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102: 257-265
3. Cao X, Qin J, Xie Y, Khan O, Dowd F, Scofield M, Lin MF, Tu Y (2006) Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells. Oncogene 25: 3719-3734
4. Chiba H, Muramatsu M, Nomoto A, Kato H (1994) Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res 22: 1815-1820
5. Chow JY, Ban M, Wu HL, Nguyen F, Huang M, Chung H, Dong H, Carethers JM (2010) TGF-b downregulates PTEN via activation of NF-kB in pancreatic cancer cells. Am J Gastrointest Liver Physiol 298: G275-G282
6. Dahiya A, Gavin MR, Luo RX, Dean DC (2000) Role of the LXCXE binding site in Rb function. Mol Cell Biol 20: 6799-6805
7. de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J, Pardali E, Le Dévédec SE, Smit VT, van der Wal A, Van't Veer LJ, Cleton-Jansen AM, ten Dijke P, van de Water B (2010) Annexin A1 regulates TGF-b signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci USA 107: 6340-6345
8. Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase- 3b regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511
9. Dinant C, Houtsmuller AB, Vermeulen W (2008) Chromatin structure and DNA damage repair. Epigenetics Chromatin 1: 9
10. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP (1994) The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79: 119-130
11. Franke TF, Kaplan DR, Cantley LC, Toker A (1997) Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275: 665-668
12. Frattini M, Signoroni S, Pilottie S (2005) Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer. Cancer Res 65: 11227
13. Hendricks KB, Shanahan F, Lees E (2004) Role for BRG1 in cell cycle control and tumor suppression. Mol Cell Biol 24: 362-376
14. Hettinger K, Vikhanskaya F, Poh MK, Lee MK, deBelle I, Zhang JT, Reddy SA, Sabapathy K (2007) c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ 14: 218-229
15. Horst D, Reu S, Kriegl L, Engel J, Kirchner T, Jung A (2008) The intratumoral distribution of nuclear b-catenin is a prognostic marker in colon cancer. Cancer 115: 2063-2070
16. Itoh N, Semba S, Ito M, Takeda H, Kawata S, Yamakawa M (2002) Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer 94: 3127-3134
17. Japanese Society for Cancer Colon and Rectum (1998) General Rules for Clinical Pathological Studies on Cancer of the Colon, Rectum and Anus, 6th edn. Kanehara: Tokyo
18. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR (1993) BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366: 170-174
19. Kingston RE, Narlikar GJ (1999) ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev 13: 2339-2352
20. Lee JY, Kang MB, Jang SH, Qian T, Kim HJ, Kim CH, Kim Y, Kong G (2009) Id-1 activates Akt-mediated Wnt signaling and p27kip1 phosphorylation through PTEN inhibition. Oncogene 28: 824-831
21. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947
22. Lin H, Wong RP, Martinka M, Li G (2010) BRG1 expression is increased in human cutaneous melanoma. Br J Dermatol 163: 502-510
23. McGhee JD, Wood WI, Dolan M, Engel JD, Felsenfeld G (1981) A 200 base pair region at the 50 end of the chicken adult b-globin gene is accessible to nuclease digestion. Cell 27: 45-55
24. Muchardt C, Yaniv M (2001) When the SWI/SNF complex remodelsythe cell cycle. Oncogene 20: 3067-3075
25. Naidu SR, Love IM, Imbalzano AN, Grossman SR, Androphy EJ (2009) The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene 28: 2492-2501
26. Ogino S, Nosho K, Irahara N, Kure S, Shima K, Baba Y, Toyoda S, Chen L, Giovannucci EL, Meyerhardt JA, Fuchs CS (2009) A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases. Clin Cancer Res 15: 4431-4438
27. Phelan ML, Sif S, Narlikar GJ, Kingston RE (1999) Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3: 247-253
28. Reisman D, Glaros S, Thompson EA (2009) The SWI/SNF complex and cancer. Oncogene 28: 1653-1668
29. Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE (2003) Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 63: 560-566
30. Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser Jr W, Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE (2002) Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression. Oncogene 21: 1196-1207
31. Roberts CW, Orkin SH (2004) The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 4: 133-142
32. Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y, Wakasugi T, Takahashi H, Funahashi H, Sato M, Takeyama H (2008) Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol 8: 56
33. Semba S, Satake S, Matsushita M, Yokozaki H (2009) Phosphatase activity of nuclear PTEN is required for CDX2-mediated intestinal differentiation of gastric carcinoma. Cancer Lett 274: 143-150
34. Sentani K, Oue N, Kondo H, Kuraoka K, Motoshita J, Ito R, Yokozaki H, Yasui W (2001) Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas. Pathobiology 69: 315-320
35. Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR, Goodglick L (2006) Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 37: 1583-1591
36. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A (1999) The cyclin D1 gene is a target of the beta-catenin/ LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527
37. Siebenlist U, Durand DB, Bressler P, Holbrook NJ, Norris CA, Kamoun M, Kant JA, Crabtree GR (1986) Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells. Mol Cell Biol 6: 3042-3049
38. Smalley MJ, Iravani M, Leao M, Grigoriadis A, Kendrick H, Dexter T, Fenwick K, Regan JL, Britt K,McDonald S, Lord CJ, Mackay A, Ashworth A (2007) Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers. Breast Cancer Res 9: R85
39. Sobin LH, Wittekind CH (1997) UICC TNM Classification of Malignant Tumors, 5th edn. John Wiley & Sons, Inc.: New York
40. Steck PA, Pershouse MA, Jasser SA, YungWK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362
41. Strober BE, Dunaief JL, Guha S, Goff SP (1996) Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family proteins. Mol Cell Biol 16: 1576-1583
42. Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C, Li B (2007) Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate 67: 203-213
43. Takeuchi T, Tomida S, Yatabe Y, Kosaka T, Osada H, Yanagisawa K, Mitsudomi T, Takahashi T (2006) Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J ClinOncol 24: 1679-1688
44. Tetsu O, McCormick F (1999) b-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426
45. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, de Bella I (2001) The Egr-1 transcription factor directly activates PTEN during irradiation-induced signaling. Nature Cell Biol 3: 1124-1128
46. Wade PA, Wolffe AP (1999) Transcriptional regulation: SWItching circuitry. Curr Biol 9: R221-R224
47. Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR (1996) Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 10: 2117-2130
48. Weintraub H, Groudine M (1976) Chromosomal subunits in active genes have an altered conformation. Science 193: 4249-4253
49. Yamamichi N, Inada K, Ichinose M, Yamamichi-Nishina M, Mizutani T, Watanabe H, Shiogama K, Fujishiro M, Okazaki T, Yahagi N, Haraguchi T, Fujita S, Tsutsumi Y, Omata M, Iba H (2007) Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res 67: 10727-10735
50. Yang JJ, Lee YJ, Hung HH, Tseng WP, Tu CC, Lee H, Wu WJ (2010) ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner. Cancer Sci 101: 1374-1381